Board approves shifting of registered office within same city and same Registrar of Companies
Asston Pharmaceuticals Ltd has informed BSE that its Board approved shifting the Registered Office.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Tuesday, 13th October 2026
- Effective Date
- 15th October 2026
- New Office Jurisdiction
- within the local limits of the same city and under the jurisdiction of the same Registrar of Companies
What the company told the exchange
Asston Pharmaceuticals Ltd has informed BSE that its Board of Directors, at a meeting held on Tuesday, 13th October 2026, considered and approved a change in the Registered Office of the Company. The meeting commenced at 04.00 P.M. and concluded at 04.20 P.M.
Where the office moves to
- From: Office No. A-431, Balaji Bhavan, 4th Floor, Plot No 42A, Sector-11 CBD Belapur, Navi Mumbai, Maharashtra, 400614
- To: Office No. 1437 and 1438, 24 High, Service Road, MIDC Industrial Area, Shiravane, Nerul, Navi Mumbai, Maharashtra – 410210
- With effect from: 15th October 2026
Why the location detail matters
The company states the new address is within the local limits of the same city and under the jurisdiction of the same Registrar of Companies. In simple terms, the Registered Office is shifting within the same city and staying under the same Registrar of Companies.
What this means for a retail investor
- The Registered Office is the company's official address on record with the Registrar of Companies and the stock exchange.
- This is an administrative change of address, communicated to the exchange as an outcome of a Board Meeting.
- Since the city and the Registrar of Companies remain the same, the change does not move the company to a different regulatory jurisdiction.
- The intimation is signed by Rishi Upadhaya, Company Secretary & Compliance Officer.
Also from Asston Pharmaceuticals
Board approves shifting of Registered Office within same city, effective 15th October 2026
13 Oct 2026
Board meeting on 13 October 2026 to consider office shift and property purchase via auction
6 Oct 2026
AGM approves MD re-appointment, new statutory auditors and higher director remuneration
1 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.